Holt Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.19M Hold
2,940
0.21% 75
2025
Q1
$1.46M Buy
2,940
+10
+0.3% +$4.98K 0.22% 70
2024
Q4
$1.52M Buy
2,930
+42
+1% +$21.9K 0.23% 69
2024
Q3
$1.79M Buy
2,888
+3
+0.1% +$1.86K 0.27% 60
2024
Q2
$1.6M Sell
2,885
-13
-0.4% -$7.19K 0.34% 52
2024
Q1
$1.68M Buy
2,898
+13
+0.5% +$7.56K 0.28% 59
2023
Q4
$1.53M Hold
2,885
0.27% 58
2023
Q3
$1.46M Hold
2,885
0.29% 58
2023
Q2
$1.51M Buy
2,885
+35
+1% +$18.3K 0.29% 57
2023
Q1
$1.64M Hold
2,850
0.33% 51
2022
Q4
$1.57M Hold
2,850
0.32% 53
2022
Q3
$1.45M Hold
2,850
0.43% 44
2022
Q2
$1.55M Sell
2,850
-150
-5% -$81.5K 0.32% 51
2022
Q1
$1.77M Hold
3,000
0.32% 56
2021
Q4
$2M Hold
3,000
0.35% 52
2021
Q3
$1.71M Hold
3,000
0.33% 58
2021
Q2
$1.51M Hold
3,000
0.29% 63
2021
Q1
$1.37M Hold
3,000
0.28% 62
2020
Q4
$1.4M Hold
3,000
0.32% 58
2020
Q3
$1.33M Hold
3,000
0.35% 55
2020
Q2
$1.09M Hold
3,000
0.3% 59
2020
Q1
$851K Hold
3,000
0.28% 58
2019
Q4
$975K Hold
3,000
0.24% 64
2019
Q3
$874K Hold
3,000
0.24% 70
2019
Q2
$881K Sell
3,000
-100
-3% -$29.4K 0.25% 72
2019
Q1
$849K Hold
3,100
0.25% 74
2018
Q4
$694K Buy
3,100
+130
+4% +$29.1K 0.22% 77
2018
Q3
$725K Sell
2,970
-130
-4% -$31.7K 0.2% 84
2018
Q2
$642K Hold
3,100
0.19% 88
2018
Q1
$640K Buy
3,100
+100
+3% +$20.6K 0.2% 85
2017
Q4
$570K Hold
3,000
0.18% 90
2017
Q3
$568K Hold
3,000
0.19% 86
2017
Q2
$523K Hold
3,000
0.18% 90
2017
Q1
$461K Hold
3,000
0.16% 95
2016
Q4
$423K Hold
3,000
0.16% 96
2016
Q3
$477K Buy
3,000
+700
+30% +$111K 0.19% 90
2016
Q2
$340K Hold
2,300
0.14% 104
2016
Q1
$326K Buy
+2,300
New +$326K 0.14% 99